SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Lidak Pharm. [LDAKA]

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: John Zwiener who wrote (245)7/8/1997 12:02:00 PM
From: luis a. garcia   of 1115
 
Thank you John there are 36 mill outstanding and of course that dampens the up move a bit. Lidakol passed 3 times already if you include the weakened drug placebo which tested almost as good as the regular drug. So its a good drug and it works.. FDA should fast track it since they cause this company damage by insisting in them weakining
the real drug to use as a placebo in the first place.. I mean the FDA screwed everybody over on this one.. so they should review the results
at their earliest oportunity...
I imagine doctors will recommend the drug for topical use in Kaposi and herpes oral and genital etc.. once its out what is to stop them from using it..
luis
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext